SCHEMBL13267271

SCHEMBL13267271

COC(=O)c1ccc(C(C)N2CCOCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
HPGD P15428 1/20 0.58
ALOX15 P16050 1/20 0.58
MGLL Q99685 1/20 0.58
HSD17B10 Q99714 1/20 0.58
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
TP53 P04637 1/20 0.48
LMNA P02545 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
OPRD1 P41143 1/20 0.48
MAPK1 P28482 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25168575 1.00 ALDH1A1 (0.58) ALDH1A1HPGDALOX15MGLLHSD17B10
SCHEMBL22227819 0.86 SLC6A2 (0.56) HPGDSMN1; SMN2NPC1RAB9AOPRD1
SCHEMBL20832766 0.86 SLC6A2 (0.56) HPGDSMN1; SMN2NPC1RAB9AOPRD1
SCHEMBL14256052 0.84 ALDH1A1 (0.57) ALDH1A1HPGDALOX15MGLLHSD17B10
SCHEMBL26199245 0.84 MC4R (0.54) ALDH1A1HPGDLMNAOPRD1KDM4E
SCHEMBL1013432 0.83 ALDH1A1 (0.50) ALDH1A1LMNAL3MBTL1OPRD1CYP3A4
SCHEMBL13267282 0.83 TSHR (0.54) ALDH1A1HPGDKMT2ASMN1; SMN2LMNA
SCHEMBL14709795 0.82 KDM4E (0.46) ALDH1A1HPGDALOX15MGLLHSD17B10
SCHEMBL1978575 0.82 OPRD1 (0.69) SMN1; SMN2NPC1RAB9AOPRD1MAPT
SCHEMBL26199219 0.82 OPRD1 (0.69) SMN1; SMN2NPC1RAB9AOPRD1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271933-A1 HETEROCYCLIC IMMUNOMODULATOR BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2023-08-31 US disclosed
US-20230271933-A1 HETEROCYCLIC IMMUNOMODULATOR BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2023-08-31 US disclosed
US-20230271933-A1 HETEROCYCLIC IMMUNOMODULATOR BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2023-08-31 US disclosed
EP-4177247-A1 HETEROCYCLIC IMMUNOMODULATOR Beijing InnoCare Pharma Tech Co., Ltd. (CN) 2023-05-10 EP disclosed
EP-4177247-A1 HETEROCYCLIC IMMUNOMODULATOR Beijing InnoCare Pharma Tech Co., Ltd. (CN) 2023-05-10 EP disclosed
CN-115776983-A Heterocyclic immunomodulators 北京诺诚健华医药科技有限公司 2023-03-10 CN disclosed
WO-2022007659-A1 HETEROCYCLIC IMMUNOMODULATOR 北京诺诚健华医药科技有限公司 2022-01-13 WO disclosed
CN-113896711-A Heterocyclic immunomodulators 北京诺诚健华医药科技有限公司 2022-01-07 CN disclosed
US-20100190766-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271933-A1 HETEROCYCLIC IMMUNOMODULATOR IL2, ICOS, IL5 ALDH1A1 233/4885HPGD 31/4885ALOX15 203/4885
US-20100190766-A1 ANTIBACTERIAL AGENTS MRPL21, SI, ABCB11 ALDH1A1 687/4885HPGD 307/4885ALOX15 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.